Biologically, the oncogene induced senesces is known to be associated with the active BRAF and may therefore permit only a small fraction of tumor cells to carry the fusion in most cases unless a secondary event occurs that enables the precursor tumor cells to progress through the RAS/RAF/ERK pathway via an overexpressed SND1-BRAF fusion. The gene discussed is BRAF; the disease is neoplasm.